Profilo
Jonathan Wang is currently Chief Executive Officer at Pinnacle Medicines Us, Inc., Independent Non-Executive Director at Frontera Therapeutics, Chief Business Officer at Zai Lab Ltd. since 2014, and Senior Associate at Ally Bridge Group HK Ltd. since 2021.
Former roles include Consultant at KPMG Hong Kong from 2013 to 2014 and Investment Manager at Navis Management Sdn.
Bhd.
Education includes a graduate degree from The University of Hong Kong in 2013, an undergraduate degree from The Hong Kong Polytechnic University in 2010, and an MBA from The Wharton School of the University of Pennsylvania.
Posizioni attive di Jonathan Wang
| Società | Posizione | Inizio |
|---|---|---|
| ZAI LAB LIMITED | Corporate Officer/Principal | 01/01/2014 |
Ally Bridge Group HK Ltd
Ally Bridge Group HK Ltd Investment ManagersFinance Ally Bridge Group invests in both public and private companies located in the United States, Hong Kong, Europe and China. The firm targets companies operating in the fields of healthcare, life sciences, disruptive technology platforms in both medical devices and biopharmaceuticals. It provides financing for buyout and growth stage capital requirements. It acts as a lead or co-lead investor. | Analista di Private Equity | 01/11/2021 |
Frontera Therapeutics
Frontera Therapeutics BiotechnologyHealth Technology Develops, manufactures and commercializes biological products & pharmaceuticals | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Jonathan Wang
| Società | Posizione | Fine |
|---|---|---|
KPMG Hong Kong
KPMG Hong Kong Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Consulente / Consigliere | 01/09/2014 |
Navis Management Sdn. Bhd.
Navis Management Sdn. Bhd. Investment ManagersFinance Navis Management invests in mid-market companies focuses on buyouts, recapitalizations and financial restructurings in Asia, particularly in enterprises with a strong or developing presence in Southeast Asia, Australia and Hong Kong with an enterprise value of USD 30 million - USD 500 million. The firm targets companies operating in the fields of consumer, healthcare, education and manufacturing sectors. The firm manages several private and public equity fund.It also acquires control of its portfolio companies and makes follow on investments. | Investitore di Private Equity | - |
Formazione di Jonathan Wang
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
University of Hong Kong
University of Hong Kong Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
KPMG Hong Kong
KPMG Hong Kong Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
The Hong Kong Polytechnic University
The Hong Kong Polytechnic University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Navis Management Sdn. Bhd.
Navis Management Sdn. Bhd. Investment ManagersFinance Navis Management invests in mid-market companies focuses on buyouts, recapitalizations and financial restructurings in Asia, particularly in enterprises with a strong or developing presence in Southeast Asia, Australia and Hong Kong with an enterprise value of USD 30 million - USD 500 million. The firm targets companies operating in the fields of consumer, healthcare, education and manufacturing sectors. The firm manages several private and public equity fund.It also acquires control of its portfolio companies and makes follow on investments. | Finance |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ally Bridge Group HK Ltd
Ally Bridge Group HK Ltd Investment ManagersFinance Ally Bridge Group invests in both public and private companies located in the United States, Hong Kong, Europe and China. The firm targets companies operating in the fields of healthcare, life sciences, disruptive technology platforms in both medical devices and biopharmaceuticals. It provides financing for buyout and growth stage capital requirements. It acts as a lead or co-lead investor. | Finance |
Zai Lab Ltd.
Zai Lab Ltd. BiotechnologyHealth Technology Develops medicine for cancer, autoimmune and infectious diseases | Health Technology |
Frontera Therapeutics
Frontera Therapeutics BiotechnologyHealth Technology Develops, manufactures and commercializes biological products & pharmaceuticals | Health Technology |
















